Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report

A 59-year-old Japanese woman was admitted for evaluation of muscle weakness. Autosomal dominant polycystic kidney disease had been diagnosed at the age of 47 years, followed by primary aldosteronism at 53 years. At the age of 58, tolvaptan was started (60 mg/day) to treat her renal disease. After 8...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Nephrol Dial
Main Authors: Kunizawa, Kyohei, Hoshino, Junichi, Mizuno, Hiroki, Suwabe, Tatsuya, Sumida, Keiichi, Kawada, Masahiro, Yamanouchi, Masayuki, Sekine, Akinari, Hayami, Noriko, Hiramatsu, Rikako, Hasegawa, Eiko, Sawa, Naoki, Takaichi, Kenmei, Shibata, Shigeru, Ubara, Yoshifumi
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2018
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5903093/
https://ncbi.nlm.nih.gov/pubmed/29692992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000487921
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados